Aura Biosciences (AURA) Share-based Compensation (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Share-based Compensation data on file, last reported at $19.3 million in Q1 2026.

• Quarterly Share-based Compensation rose 449.23% year-over-year to $19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.3 million (up 56.57% YoY) and the FY2025 annual result came in at $14.3 million, up 9.29% from the prior year.
• Share-based Compensation rose to $19.3 million in Q1 2026, from $3.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $19.3 million in Q1 2026 to a low of $1.3 million in Q2 2022.
• A 5-year average of $4.2 million and a median of $2.8 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation surged 761.62% — and 2025, when it advanced 11.75%.
• Tracing AURA's Share-based Compensation over 5 years: stood at $1.8 million in 2022, then jumped by 43.5% to $2.6 million in 2023, then grew by 12.83% to $2.9 million in 2024, then advanced by 11.75% to $3.3 million in 2025, then surged by 488.06% to $19.3 million in 2026.
• The last three Share-based Compensation figures came in at $19.3 million (Q1 2026), $3.3 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.